Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the clinical effect of rapamycin combined with TACE on early-stage HCC with
overexpression of ASPH after radical surgery using randomized controlled study and provide a
new anti-recurrence treatment for HCC patients after operation.